← ANALYST RATINGS · TIPRANKS
OrthoPediatrics (KIDS): analyst forecast and price target
Analyst consensus
Moderate Buy2 Buy0 Hold0 Sell
Ratings of 2 analysts in the last 3 months · top analysts only12-month forecast
Based on 2 price targets given in the last 3 months, the average target is $29.00, the highest $35.00, the lowest $23.00. The average is +32.1% from the last price of $21.95.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $23.00 → $23.50+2.2% | Hold | +7.1% | Reiterated | 15.10.26on TipRanks 00:05 | — | |
| Ryan Zimmerman★★★★★★★★★★#3375 · hits 46% · avg +3.3% | BTIG | $29.00 | Buy | +32.1% | Reiterated | 15.09.26on TipRanks 06:25 | +4.5%next day +0.1% · 5 days −4.4% | ↗ |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $28.00 | Buy | +27.6% | Upgrade | 24.08.26on TipRanks 01:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $27.00 | Hold | +23.0% | Reiterated | 24.08.26on TipRanks 01:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $28.00 | Hold | +27.6% | Reiterated | 24.08.26on TipRanks 01:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $26.00 | Hold | +18.5% | Reiterated | 24.08.26on TipRanks 01:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $29.00 | Buy | +32.1% | Upgrade | 24.08.26on TipRanks 01:05 | — | |
| Caitlin Roberts★★★★★★★★★★#1832 · hits 65% · avg +14.7% | Canaccord Genuity | $28.00 | Buy | +27.6% | Reiterated | 12.08.26on TipRanks Aug 13 08:40 | +2.3%next day −0.1% · 5 days +7.0% | ↗ |
| Ben Haynor★★★★★★★★★★#11216 · hits 35% · avg −2.8% | Lake Street | $34.00 | Buy | +54.9% | Reiterated | 05.08.26on TipRanks 09:10 | +7.0%next day +2.5% · 5 days +11.1% | ↗ |
| Ravi Misra★★★★★★★★★★#11202 · hits 35% · avg −10.7% | Truist Financial | $20.00 → $22.00+10.0% | Hold | +0.2% | Reiterated | 05.08.26on TipRanks 07:55 | +7.0%next day +2.5% · 5 days +11.1% | ↗ |
| Matthew O'Brien★★★★★★★★★★#12031 · hits 41% · avg −4.5% | Piper Sandler | $22.00 → $25.00+13.6% | Buy | +13.9% | Reiterated | 05.08.26on TipRanks 07:20 | +7.0%next day +2.5% · 5 days +11.1% | ↗ |
| Rick Wise★★★★★★★★★★#7800 · hits 51% · avg +0.1% | Stifel Nicolaus | $22.00 → $24.00+9.1% | Buy | +9.3% | Reiterated | 05.08.26on TipRanks 07:15 | +7.0%next day +2.5% · 5 days +11.1% | ↗ |
| Michael Matson★★★★★★★★★★#1853 · hits 50% · avg +6.0% | Needham | $35.00 | Buy | +59.5% | Reiterated | 05.08.26on TipRanks 04:56 | +7.0%next day +2.5% · 5 days +11.1% | ↗ |
| Mathew Blackman★★★★★★★★★★#2177 · hits 49% · avg +9.2% | TD Cowen | $23.00 | Buy | +4.8% | Reiterated | 04.08.26on TipRanks Aug 5 02:55 | −1.8%next day +7.0% · 5 days +16.2% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering OrthoPediatrics
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $27.50 at a price of $22.27 (+23.5%); now: $27.50 at $21.95 (+25.3%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 1 | 1 | 1 | 1 |
| Buy | 0 | 1 | 1 | 2 | 1 | 1 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 27.10.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.21 (from $-0.33 to $-0.15). Last quarter: $-0.30.
Sales
Next quarter’s sales estimate — $68M (from $68M to $69M). Last quarter: $71M.
Best top-analyst consensus in the sector · Healthcare
About OrthoPediatrics
- CEO: David R. Bailey
- Employees: 602
- 2850 Frontier Drive, Warsaw, IN, 46582, US
- www.orthopediatrics.com
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
Data from the stock’s TipRanks forecast page, read 4 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗